Abstract
Leukemia was the first malignancy linked to radiation exposure in atomic bomb survivors. Clear evidence of the dose-dependent excess risk of three major types of leukemia (acute lymphocytic leukemia, acute myeloid leukemia [AML], and chronic myeloid leukemia) was found, especially in people exposed at young ages. Such leukemia risks were at their highest in the late 1950s, and declined gradually thereafter over the past 50 years. Findings from recent risk analyses, however, suggest the persistence of AML risk even after 1990, and evidence of increased risk of myelodysplastic syndromes (MDS) due to atomic bomb radiation has recently been shown. High-risk MDS and forms involving complex chromosomal aberrations were found to be much more frequent in people exposed to higher radiation doses. These lines of epidemiological evidence suggest that the risk of radiation-induced hematological malignancies has persisted for six decades since the initial exposure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fo1ley JH, Borges W, Yamasaki T. Incidence of leukemia in the atomic bomb survivors of Hiroshima and Nagasaki, Japan. Am J Med. 1952;13:311–21.
Ishimaru T, Hoshino T, Ichimaru M, Okada H, Tomiyasu T. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 (October), pp. 1950–30, September 1966. Radiat Res. 1971;45(1):216–33.
Ichimaru M, Ishimaru T, Belsky JH. Incidence of leukemia in Atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950–71. Radiation dose, years after exposure, age at exposure, and type of leukemia. J Radiat Res. 1978;19:262–82.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976;33:451–8.
Matsuo T, Tomonaga M, Bennett JM, Kuriyama K, Imanaka F, Kuramoto A, et al. Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia. Jpn J Clin Oncol. 1988;18:91–6.
Tomonaga M, Matsuo T, Carter RL, et al. Differential effects of atomic bomb irradiation in inducing major leukemia types: analyses of open-city cases including the Life Span Study cohort based upon update diagnostic systems and the dosimetry system 1986 (DS86). RERF TR 9-91. 1993.
Kamada N, Tanaka K, Oguma N, Mabuchi K. Cytogenetic and molecular changes in leukemia among atomic bomb survivors. J Radiat Res (Tokyo). 1991;32(Suppl 2):257–65.
Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic-bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res. 1994;137:S68–97.
Richardson D, Sugiyama H, Nishi N, Sakata R, Shimizu Y, Grant EJ, Soda M, Hsu WL, Suyama A, Kodama K, Kasagi F. Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950–2000. Radiat Res. 2009;172:368–82.
Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189–99.
Iwanaga M, Hsu WL, Soda M, Takasaki Y, Tawara M, Joh T, Amenomori T, Yamamura M, Yoshida Y, Koba T, Miyazaki Y, Matsuo T, Preston DL, Suyama A, Kodama K, Tomonaga M. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. J Clin Oncol. 2011;29:428–34.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tsushima, H., Iwanaga, M. & Miyazaki, Y. Late effect of Atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes. Int J Hematol 95, 232–238 (2012). https://doi.org/10.1007/s12185-012-1002-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-012-1002-4